Cargando…

A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe

Psychedelics are used for various pathologies of the central nervous system and are currently the subject of much research, some of which relates to the compounds contained in various Psilocybe-type hallucinogenic mushrooms. It is difficult, however, to obtain and purify sufficient quantities of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Serreau, Raphaël, Amirouche, Ammar, Benyamina, Amine, Berteina-Raboin, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867295/
https://www.ncbi.nlm.nih.gov/pubmed/36678537
http://dx.doi.org/10.3390/ph16010040
_version_ 1784876306763087872
author Serreau, Raphaël
Amirouche, Ammar
Benyamina, Amine
Berteina-Raboin, Sabine
author_facet Serreau, Raphaël
Amirouche, Ammar
Benyamina, Amine
Berteina-Raboin, Sabine
author_sort Serreau, Raphaël
collection PubMed
description Psychedelics are used for various pathologies of the central nervous system and are currently the subject of much research, some of which relates to the compounds contained in various Psilocybe-type hallucinogenic mushrooms. It is difficult, however, to obtain and purify sufficient quantities of these compounds from fungi to carry out biological studies, hence the need to develop simple and efficient synthetic routes. We review here the various syntheses used to obtain these molecules, focusing first on the classic historical syntheses, then the use of more recent metallo-catalyzed couplings and finally the known biocatalytic methods for obtaining these molecules. Other access routes are certainly possible and should be the subject of future research given the therapeutic interest of these compounds.
format Online
Article
Text
id pubmed-9867295
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98672952023-01-22 A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe Serreau, Raphaël Amirouche, Ammar Benyamina, Amine Berteina-Raboin, Sabine Pharmaceuticals (Basel) Review Psychedelics are used for various pathologies of the central nervous system and are currently the subject of much research, some of which relates to the compounds contained in various Psilocybe-type hallucinogenic mushrooms. It is difficult, however, to obtain and purify sufficient quantities of these compounds from fungi to carry out biological studies, hence the need to develop simple and efficient synthetic routes. We review here the various syntheses used to obtain these molecules, focusing first on the classic historical syntheses, then the use of more recent metallo-catalyzed couplings and finally the known biocatalytic methods for obtaining these molecules. Other access routes are certainly possible and should be the subject of future research given the therapeutic interest of these compounds. MDPI 2022-12-28 /pmc/articles/PMC9867295/ /pubmed/36678537 http://dx.doi.org/10.3390/ph16010040 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Serreau, Raphaël
Amirouche, Ammar
Benyamina, Amine
Berteina-Raboin, Sabine
A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe
title A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe
title_full A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe
title_fullStr A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe
title_full_unstemmed A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe
title_short A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe
title_sort review of synthetic access to therapeutic compounds extracted from psilocybe
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867295/
https://www.ncbi.nlm.nih.gov/pubmed/36678537
http://dx.doi.org/10.3390/ph16010040
work_keys_str_mv AT serreauraphael areviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe
AT amiroucheammar areviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe
AT benyaminaamine areviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe
AT berteinaraboinsabine areviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe
AT serreauraphael reviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe
AT amiroucheammar reviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe
AT benyaminaamine reviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe
AT berteinaraboinsabine reviewofsyntheticaccesstotherapeuticcompoundsextractedfrompsilocybe